豚鼠胰腺内telocytes形态学特点及甲磺酸伊马替尼对telocytes的干预作用
[Abstract]:Objective to observe and analyze the morphologic characteristics of telocytes-TCs in guinea pig pancreas and to investigate the effect of imatinib mesylate on TCs. Methods Nine-week-old guinea pig pancreas was used to observe and analyze TCs immunological markers (c-kit / CD _ (117) vimentin) by immunohistochemical staining. The ultrastructure of TCs was observed by transmission electron microscope. The model of imatinib mesylate intervention was established: 54 guinea pigs, male and female, were divided into two groups: normal control group and control group. The changes of TCs were observed by immunohistochemical staining of TCs in the treated group (W _ (14) W _ (14) W _ (21) W _ (21) and W _ (28) d); and the expression of CD117vimentin protein in pancreatic tissue was observed by Western blot. Results Immunohistochemical staining showed that TCs in the pancreas was located in connective tissue. The cells were triangular and fusiform. There were one or more long and thin processes around the acinar and connected to form the network structure. The ultrastructure of electron microscope showed that TCs had the slender bulge of rosary, the nucleus and cytoplasm were relatively high, the cytoplasm contained a small amount of mitochondria and the smooth endoplasmic reticulum, etc. After the intervention of imatinib mesylate, the process of TCs became shorter, the network structure decreased, and gradually recovered after drug withdrawal. After treatment, the expression of c-kit/CD117 and vimentin protein in pancreatic tissue decreased, and gradually recovered after withdrawal, the difference was statistically significant (P0.05). Conclusion in the pancreas of guinea pig, the spindle shape and the rosary protuberance form the network structure around the acinar, and imatinib mesylate affects the morphology and protein expression of TCs in the pancreas.
【作者单位】: 贵州医科大学基础医学院人体组织学与胚胎学教研室;
【基金】:贵州省科技厅基金{黔科合J字[2008]2277} 贵阳市科技局贵州医科大学联合基金{[20161001]013}~~
【分类号】:R965
【相似文献】
相关期刊论文 前10条
1 郑斌;危晴岚;刘茂柏;;甲磺酸伊马替尼临床研究概况[J];海峡药学;2006年06期
2 李玉兰;;极谱法测定尿液中甲磺酸伊马替尼含量[J];药物分析杂志;2008年06期
3 李铭东;李东;吉民;;甲磺酸伊马替尼的合成[J];中国药学杂志;2008年03期
4 付利强;王鹏;程卯生;赵冬梅;;甲磺酸伊马替尼合成路线图解[J];中国医药工业杂志;2008年10期
5 赵瑾;姜达;;甲磺酸伊马替尼耐药机制及其逆转研究进展[J];癌症进展;2009年02期
6 许鹏飞;张春桃;;甲磺酸伊马替尼合成新工艺[J];科技传播;2010年23期
7 陈灵娟;周和平;黄文峰;闫明;姚军;;甲磺酸伊马替尼的合成[J];河北科技大学学报;2011年05期
8 王保国;刘玉凤;狄国杰;许鹏飞;朱鹏;付茂文;;甲磺酸伊马替尼的合成[J];济宁医学院学报;2012年02期
9 刘颖;张克星;兰静;王yN;田青松;;离子色谱法测定甲磺酸伊马替尼中甲磺酸[J];现代药物与临床;2012年04期
10 丁倩倩;陈勤奋;;甲磺酸伊马替尼的临床应用[J];上海医药;2013年03期
相关重要报纸文章 前2条
1 上海华联制药有限公司技术中心 马培奇;抗肿瘤新药:甲磺酸伊马替尼[N];中国高新技术产业导报;2001年
2 伊遥;洋品牌的幸福时光[N];医药经济报;2012年
相关硕士学位论文 前1条
1 杜艳玲;甲磺酸伊马替尼及其片剂的质量标准研究[D];河北医科大学;2015年
,本文编号:2159665
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2159665.html